308 related articles for article (PubMed ID: 3708213)
1. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
Fitzgerald MF; Moncada S; Parente L
Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
[TBL] [Abstract][Full Text] [Related]
2. The release of lyso-PAF from guinea-pig lungs.
Parente L; Fitzgerald M; De Nucci G; Moncada S
Eur J Pharmacol; 1985 Jun; 112(2):281-4. PubMed ID: 4029263
[TBL] [Abstract][Full Text] [Related]
3. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Pretolani M; Lefort J; Malanchère E; Vargaftig BB
Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
[TBL] [Abstract][Full Text] [Related]
4. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection.
Pretolani M; Lefort J; Vargaftig BB
Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509
[TBL] [Abstract][Full Text] [Related]
5. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
Lefort J; Rotilio D; Vargaftig BB
Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
[TBL] [Abstract][Full Text] [Related]
7. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
[TBL] [Abstract][Full Text] [Related]
8. Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.
Pretolani M; Lefort J; Dumarey C; Vargaftig BB
J Pharmacol Exp Ther; 1989 Jan; 248(1):353-9. PubMed ID: 2464060
[TBL] [Abstract][Full Text] [Related]
9. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
Detsouli A; Lefort J; Vargaftig BB
Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
[TBL] [Abstract][Full Text] [Related]
10. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Berti F; Omini C; Rossoni G; Braquet P
Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
[TBL] [Abstract][Full Text] [Related]
11. The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations.
Benveniste J; Boullet C; Brink C; Labat C
Br J Pharmacol; 1983 Sep; 80(1):81-3. PubMed ID: 6652376
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
[TBL] [Abstract][Full Text] [Related]
13. PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.
Stahl GL; Lefer DJ; Lefer AM
Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):459-63. PubMed ID: 3431598
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
Harczy M; Maclouf J; Pradelles P; Braquet P; Borgeat P; Sirois P
Pharmacol Res Commun; 1986 Aug; 18 Suppl():111-7. PubMed ID: 3095849
[TBL] [Abstract][Full Text] [Related]
15. Effect of human recombinant interleukin-5 on in vitro responsiveness to PAF of lung from actively sensitized guinea-pigs.
Pretolani M; Lefort J; Leduc D; Vargaftig BB
Br J Pharmacol; 1992 Jul; 106(3):677-84. PubMed ID: 1380388
[TBL] [Abstract][Full Text] [Related]
16. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
[TBL] [Abstract][Full Text] [Related]
17. PAF-acether and experimental anaphylaxis as a model for asthma.
Pretolani M; Lellouch-Tubiana A; Lefort J; Bachelet M; Vargaftig BB
Int Arch Allergy Appl Immunol; 1989; 88(1-2):149-53. PubMed ID: 2540093
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of platelet-activating factor in the guinea-pig heart.
Triggiani M; Chilton FH
J Mol Cell Cardiol; 1992 Oct; 24(10):1101-11. PubMed ID: 1479612
[TBL] [Abstract][Full Text] [Related]
19. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.
Darius H; Lefer DJ; Smith JB; Lefer AM
Science; 1986 Apr; 232(4746):58-60. PubMed ID: 3082008
[TBL] [Abstract][Full Text] [Related]
20. Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion.
Lellouch-Tubiana A; Lefort J; Pfister A; Vargaftig BB
Int Arch Allergy Appl Immunol; 1987; 83(2):198-205. PubMed ID: 3583412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
